Companies/Genix Pharmaceuticals Corporation

Company profile

Genix Pharmaceuticals Corporation

OTC: GENPF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenuebottom-decile growth

EA Score

——

FH 5DQ —GM —SS 51

v0.1 · 35/100 weight · pillars only

↑ workforce scale, disclosure history · ↓ revenue growth (YoY), Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$239.2k

Employees

4,000

Market cap

$924.5k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$239.2k-335.0k CAD2025

Operating income-$109.4k-153.3k CAD2025

Total assets$36.4k51.0k CAD2025

Liabilities$1.0M1.5M CAD2025

Equity-$1.0M-1.4M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$326.3k

FY18

$103.4k

FY19

FY20

FY21

FY22

$9.2k

FY23

$3.0k

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Genix Pharmaceuticals Corporation booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

LiveWire Ergogenics, Inc.——Dermata Therapeutics, Inc.——Genprex, Inc.34D AIM ImmunoTech Inc.36D

Key facts

CEOSina Salehi Pirooz

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: GENPF

Employees4,000

IPO date2020-02-18

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.